In Vivo Confocal Microscopic Observations of Vortex Keratopathy in Patients with Amiodarone-Induced Keratopathy and Fabry Disease

Table 1

Clinical Findings of Amiodarone Patients.

			Durations and dosage of drugs until vortex keratopathy was detected				Durations until microdots were detected by IVCM		Final stage of vortex keratopathy
			By IVCM		By slit-lamp microscopy
Case number	Sex	Age	Duration (days)	Dosage (mg)	Duration (days)	Dosage (mg)	Stroma (days)	Endothelium (days)	Stage OD/OS	Days OD/OS
1	M	48	7	2600	39	9000	74	ND	3/3	194/194
2	W	82	35	3600	63	6400	35	63	3/3	190/190
3	M	72	14	3200	14	3200	60	ND	3/3	181/181
4	M	81	67	6700	192	38,600	ND	ND	2/2	374/374
5	M	70	21	4400	21	4400	ND	ND	2/2	173/173
6	W	77	15	2300	78	8600	32	32	2/2	183/183
7	W	87	65	6450	65	6450	65	ND	1/1	339/339
8	M	74	ND	ND	ND	ND	ND	ND	0/0	180/180
Average		73.9	32.0	4178.6	67.4	10,950	53.2	47.5	2/2	226.8/226.8